释放治疗潜力:探索脑癌治疗中的核受体
Sujitha Jayaprakash1, Hiu Yan Lam2,3, Ravichandran Vishwa1
1Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.
Chinese medical journal
|August 25, 2025
概括
脑癌是一种致命的疾病, 核受体 (NRs) 涉及到脑瘤的生长和对治疗的抵抗,提供潜在的新治疗点.
科学领域:
- 癌症学
- 分子生物学
- 内分泌学
背景情况:
- 脑癌是全球癌症死亡的主要原因,
- 核受体是细胞过程的关键调节者, 它们的失调与癌症越来越相关.
- 特定的NR异常促进了脑瘤的侵袭性特征,包括生存,增殖和治疗耐药性.
研究的目的:
- 审查关键核受体 (NR) 在脑癌发育和进展中的作用.
- 在恶性脑瘤中检查NR的预后意义.
- 评估针对脑癌的治疗潜力.
主要方法:
- 对脑癌中核受体的研究进行文献综述.
- 分析不同类型的大脑瘤中的NR表达和功能.
- 对NR向治疗的临床前和临床数据的评估.
主要成果:
- 异常的NR信号有助于大脑瘤的标志性癌症表型.
- 一些NR的表达变化与患者的预后有关.
- 在临床前模型中,针对特定的NR用激动剂或抗剂显示出治疗前景.
结论:
- 核受体在脑癌的发病过程中起着重要作用.
- 对于大脑恶性瘤来说,NRs是有前途的预后生物标志物和治疗点.
- 对NR向治疗的进一步研究可能会为脑癌患者改善治疗策略.
相关概念视频
01:31Transducer Mechanism: Nuclear Receptors
1.6K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.6K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K